Novavax says COVID-19 vaccine 89% effective, less for South Africa variant

UPI on South Carolina

Jan 29, 2021

Jan. 29 (UPI) -- Biotech Novavax says its COVID-19 vaccine has proven in late-stage clinical trials to be almost 90% effective, though it shows a less robust response to the South…